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Yield of esophagogastroduodenoscopy and
colonoscopy in cancer of unknown primary
Muhammad Tayyab Usmani1, Abdullah Bin Khalid2, Syed Hasnain Ali Shah3,
Tauseef Ahmad4, Saeed S. Hamid5, Syed M. Wasim Jafri6
ABSTRACT
Objectives: Carcinoma of unknown primary origin (CUP) is heterogeneous group of cancers. Role of
gastrointestinal (GI) endoscopy in this entity is under investigated. Aim of this study was to evaluate yield
of Colonoscopy and Esophagogastroduodenoscopy (EGD) in localizing primary tumor in patients with CUP.
Methodology: Patients with histopathologically proven CUP who underwent colonoscopy / EGD to find the
primary tumor from December 2009 to December 2011 were included in the study. Abdominal symptoms
and cytokeratin (CK) 7 and 20 markers were correlated with presence of primary in GI tract.
Results: After giving informed consent 86 patients were included in final analysis. All patients underwent
colonoscopy while 60(70%) got EGD along with colonoscopy. Mean age was 55.10 +/-11.94 years with
52(60%) male. Abdominal symptoms were present in 50%. CK7+/CK20- in 34(40%); CK7-/CK20+ in 2(2%)
while CK7+/20+ in 7(8%) of metastatic tumor samples. Liver was metastatic site in 47(55%), Lymph node
12(14%) and Ascites in 8(9%). Endoscopy detected primary in 6 (7%) patients with 3 each in stomach and
colon. No association of abdominal symptoms and cytokeratin markers was found with presence of GI
primary site.
Conclusion: Yield of localizing primary lesion in the GI tract by pan-endoscopy was limited. Abdominal
symptoms and cytokeratin markers do not predict presence of gastrointestinal malignancies.
KEY WORDS: Esophagogasrtoduodenoscopy (EGD), Colonoscopy, Cancer of unknown primary (CUP).
doi: http://dx.doi.org/10.12669/pjms.292.3212
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INTRODUCTION
Carcinoma of unknown primary origin (CUP) is
a heterogeneous group of cancers defined by the
presence of metastatic disease with no identified
primary tumor at presentation.1 It comprised 2%
of all cancer in recent year and occurring mostly in
6th and 7th decade of life.2,3 The condition carries a
poor prognosis with the average survival from 6 to
9 months.4 An extensive search to find the primary
tumor is usually carried out. Even after extensive
investigations that include imaging, endoscopies
and immunohistochemistry studies the frequency
of detection of a primary tumor is only upto 30%.5
Finding primary site not only have important
bearing on therapeutic decisions by the physician4
but it also has prognostic implications.6 Some tumors
especially metastatic colonic adenocarcinoma even
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at stage 3 and 4 has a 5 year survival ranging from
6% to 45%7 as opposed to hardly few months
average survival for CUP.5
Guidelines and practices differ regarding the
use of gastrointestinal (GI) endoscopies in finding
the primary site. European Society for medical
oncology (ESMO) guidelines8 recommend these
endoscopies only if GI symptoms are present while
National Comprehensive Cancer Network (NCCN)
suggest esophagogastroduodenoscopy (EGD) /
colonoscopy should be symptom directed and in
addition to that colonoscopies should be performed
in cases of adenocarcinoma or carcinoma unspecified
metastasizing to the liver. EGD is also indicated if
suspicion of finding primary in the upper GI tract
is high based on the patient’s symptoms or other
laboratory or radiological parameters.8,9 Immunehistochemistry with cytokeratin (CK) markers
like CK 7 and 20 are routinely used for the tissue
specimen. CK 7/20 positivity and/or negativity
influences the decision to perform upper or lower
GI endoscopies as they may direct towards the
primary site in the GI tract.4,8,10
An invasive approach of EGD and colonoscopy
must take into account the low yield of finding the
primary. It therefore seems imperative to evaluate
yield of these endoscopies in finding the primary
site and whether any risk factors associated with
presence of primary in GI tract. There is little data
available related to yield of colonoscopy and EGD
in determining the primary site in patients with
CUP. The aim of our study was to evaluate the yield
of colonoscopy and EGD in localizing primary tumor in patients with CUP. It also looked into the
association of abdominal symptoms and CK 7 and
20 markers with the presence of GI primary.
METHODOLOGY
Patient and methods: This cross sectional study
was conducted from December 2009 to December
2011 at The Aga Khan University Hospital on
patients diagnosed as having biopsy proven CUP
defined by the presence of metastatic disease with
no identified primary tumor at presentation. The
study protocol was approved by the Hospital Ethics
review committee.
A total of 102 patients having CUP had colonoscopy and/ or EGD for GI symptoms, radiology
and CK marker were enrolled after informed consent. EGD and colonoscopy were performed based
upon the history, site, histopathology, tumor markers and radiology findings. Patients with unknown
primary and having these procedures for upper
524 Pak J Med Sci 2013 Vol. 29 No. 2
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GI bleed and perforation were excluded from the
study. Similarly patients with deranged coagulation or on therapeutic anticoagulation were also excluded. Detailed history with particular emphasis
on gastrointestinal related complaints like abdominal pain, bleeding per rectum and altered bowel
habits were taken. Physical examination was carried out in every patient. All the data was collected
on a predesigned questionnaire.
EGD and colonoscopies were done under
conscious sedation with intravenous midazolam
and fentanyl by gastroenterologists with Olympus
GIF-Q 180 video scope and Olympus CF 180 AL
Colonoscope respectively. Normal coagulation
was assured before these procedures. Pulse, Blood
Pressure and oxygen saturation were monitored
before the start of procedure and every five minutes
till completion. Details on preparation of colon,
nature and location of the lesions were recorded.
All lesions found at endoscopies were biopsied and
sent for histo-pathological examination. Specimens
were examined by at least two histopathologists
before reporting.
Statistical analysis: Descriptive statistics were
calculated for continuous variables such as age,
haemoglobin Mean ± SD were computed. For categorical variables such as gender, abdominal pain,
biopsy site, histo-pathological type of lesion and
radiological findings, the frequencies and percentages were calculated. The chi-square test was applied to assess the association of different variables
like abdominal symptoms, cytokeratin markers
with the primary lesion. P < 0.05 was considered
significant. P value greater than this is reported as
NS (Non-significant). Data entry and analysis were
performed using the Statistical Packages for Social
Sciences version 17(SPSS, Chicago, Illinois, USA).
RESULTS
A total of 102 patients of CUP were detected
during study period. Out of which 86 patients
underwent endoscopic procedures and were
considered for final analysis. Detail of the excluded
patients is given in Fig.1.
Of the 86 patients, the mean age of presentation
was 55.10 +/- 11.94 years among which 71(82.5%)
patients were from 41 to 69 years of age. The
youngest patient was 23 years and the eldest was 85
years at the time of diagnosis. The male population
comprised of 52 (60.46%) patients. Among all 86
patients abdominal pain, altered bowl habits and
bleeding per rectum were present in 46.5%, 14%
and 7%, respectively. The basic demographics
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Table-I: Demographics, Radiological
and Cytokeratin markers.
Demographics, Symptoms,
radiological and tumor markers

Fig.1: Flow Chart.

along with the radiologic findings and CK markers
distributions are given in Table-I.
The mean hemoglobin was 11.36 gms/dl having
normochromic and normocytic picture. The
predominant metastatic site was liver in 47(55%)
patients followed by lymph nodes in 12(14%)
patients, respectively. (Table-II) Among the 7(8.13%)
bone biopsies five were from the vertebrae, while
one each from scapula and right iliac crest. The soft
tissue biopsy sites included buttock and a forearm
nodule. Single metastatic deposit was in ovary,
prostate and urinary bladder. The histopathology
of the metastatic deposit was predominantly either
adenocarcinoma or various sub-types of the same.
(Table-III)
CK7 was positive in 34 (40%) while CK 20 was
positive in 2 (2%) patients, respectively. CK 7/20
positive in 7 (8%) patients while both were negative
in 43 (50%). Two patients with both CK7 and 20
positive were found to have malignancy in stomach
and rectum, respectively. While among the two
patients with CK7 positivity were found to have
the primary in sigmoid and stomach respectively.
The remaining two patients who were negative for
both CK7 and CK20 had their primary found in
stomach and transverse colon. The p-value for the
cytokeratin markers with primary found in GI tract
was found to be p = 0.46. (Table-IV)
All patients 86(100%) underwent colonoscopy
while 60 (70%) patients underwent EGD in addition
to colonoscopy according to the inclusion criteria.
Primary tumor was detected in 6 (7%) patients. In

n = 86 (%)

Gender
Male
Female
Age (years)
Previous Malignancy
Smoker
Alcohol
Weight loss
Abdominal symptoms
Hemoglobin (gms /dl)
Radiological findings
Ascites
Omental caking and mesenteric
metastasis
Vertebral metastasis
Lymph nodes
Hepatic metastasis
Cytokeratin markers
CK 7+/CK 20CK 7-/CK 20+
CK7+/CK20+
CK 7-/CK 20-

52 (60.46 )
34 (39.54 )
55.10 +/-11.94
1 (1.1 )
28 (32.55)
3 (3.48)
39(45.34)
43(50)
11.36 ± 2.29
28 ( 32.55)
26 (30.23)
17 (19.76)
37 (43.02)
56 (65.11)
34(39.53)
2(2.32)
7(8.13)
43(50)

three (3.48%) patients primary tumor was found in
the stomach while in remaining three it was in colon. Among these three each has a malignancy in
rectum, sigmoid and transverse colon respectively.
Out of the 86 colonoscopies 6(7%) patients had either an ulcer or a mass in their colon. Three (50%)
out of these 6 patients with abnormal findings got
their primary identified as a result of biopsy. Similarly out of 15 (17.4%) ulcers or a mass found at
EGD, 3 (20%) turned out to be the source of primary.
Sub group analysis of the patients with
adenocarcinoma of all categories along with
unspecified carcinoma metastasizing to liver was
done. There were a total of 44 patients among them
Table-II: Site of metastatic involvement.
Biopsy site
Frequency (%)
			
Liver
Lymph nodes
Ascitic fluid
Bone
Omentum
Soft tissue
Pleural fluid
Viscera

47 (54.65%)
12 (13.89%)
8 (9.30%)
7 (8.13%)
5 (5.81%)
2 (2.2%)
2 (2.2%)
3 (3.48%)
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Primary
on EDG

Primary
on Colon

1
0
0
0
0
1
1
0

1
0
0
0
1
0
0
1
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Table-III: Histopathology of the metastatic site and their subsequent outcome on endoscopy.
Biopsy of metastatic site
Adenocarcinoma
Poorly differentiated adenocarcinoma
Infiltrating adenocarcinoma
Neuroendocrine differentiation
Large cell carcinoma
Papillary carcinoma
Squamous cell carcinoma
Mucin secreting adenocarcinoma
Signet ring adenocarcinoma
Untype-able carcinoma

Primary tumor not found Primary found on EGD Primary found on colon Total (%)
62
4
4
3
2
2
1
1
0
1
80

25 (56.8%) had abdominal symptoms while 18(41%)
of patients were CK7-/20-. One primary was found
out as a result of colonoscopy in this particular
group. The p value for abdominal symptoms and
cytokeratin markers with respect to primary found
in colon was 0.451 and 0.806 respectively.
DISCUSSION
This study showed a yield of around 7% in CUP by
virtue of EGD and colonoscopy. However it failed
to elaborate any co-relation between the different
variables and EGD / colonoscopy with respect to
this specific entity. The mean age of presentation
in this study was 55 years as opposed to 59 years
as reported from the literature from the West.3 In
our study three patients were found to have cancer
in the colon and in three patients the primary was
found in the stomach. Overall there was no association between the abdominal symptoms and finding
the primary in the gastrointestinal tract however
two out of the three patients with primary found in
the colon had abdominal pain.
In our study liver, lymph nodes and ascitic fluid were the most frequently involved sites for the
metastatic disease respectively. In this regard Disibio et al in an autopsy based study concluded that
lymph nodes are the most common site of metastasis (20.6%).11 Several studies have quoted different
frequency of organ involvement depending upon
the histo-pathological types of the disease.12,13
The expression of certain cytokeratin markers
may help in differentiating the site of origin of different metastatic carcinomas. In our study, among
three patients with metastatic colon cancers we
found that CK 7 and 20 were both positive in one
patient, both negative in another patient and the
third patient had CK 7 positive with CK 20 negative.
Previous studies have shown that CK 7 negativity
with CK 20 positivity has the greatest predilection
526 Pak J Med Sci 2013 Vol. 29 No. 2
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2
1
0
0
0
0
0
0
0
0
3

1
1
0
0
0
0
0
0
1
0
3

65 (75.58)
6 (6.97)
4 (4.65)
3 (3.48)
2 (2.2)
2 (2.2)
1 (1.1)
1 (1.1)
1 (1.1)
1 (1.1)
86 (100%)

for colorectal cancers.14 However, it has also been
demonstrated that upto 17% of colon cancers are
positive for CK 7 whereas upto 19% of these tumors
are negative for CK 20.15 Hence although CK7+/
CK20- pattern in metastatic biopsy may point towards gastric cancer primary yet its absence does
not rule out the possibility of primary colorectal
neoplasm.15
In our study one out of three patients who had
primary at stomach showed sole positivity for CK 7,
none of the patients was sole CK 20 positive. However, single patient with CK7/20 positivity found to
have primary residing in the stomach. This was also
shown in study done by Pavlidis N.10 In contrast to
colorectal adenocarcinoma; gastric adenocarcinomas have a heterogeneous expression of CK7/20.
Studies have shown that CK 7-/20- pattern is seen
in 10% gastric cancers while CK20+/7- pattern is
seen in upto 33% of gastric adenocarcinomas while
the rest exhibit mixed pattern.14,16-18 We also did not
find any association of finding CK 7 or CK 20 with
the detection of primary tumor. This is most likely
because of small number of primary tumors in our
cohort or because of heterogeneity of expression of
these markers as observed by others as well.
It is interesting that there was no association of
abdominal symptoms and detection of primary
tumor in our study (p value NS). Studies have
shown that patients with CUP mostly present with
non specific symptoms of anorexia, weakness and
Table-IV: Correlation of abdominal symptoms and
cytokeratin markers with the site of primary.
Primary found Primary found P value
at EGD
at Colonoscopy
Abdominal symptoms
CK 7-/20CK7+/20+
CK7+/20-

1
1
1
1

2
1
1
1

0.717
0.469
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weight loss. Early dissemination and lack of specific
clinical features are hall mark of these malignancies. Moreover if there would have been prominent
gastrointestinal symptoms those cases would have
been detected earlier on with appropriate symptom
directed investigations like colonoscopies and/or
gastroscopies before their metastasis would come
to lime light.
Sub group of patients having adenocarcinoma
or carcinoma unspecified metastasizing to liver
which underwent colonoscopy as indicated by
NCCN guidelines, shows a poor yield of only one
primary found as a result of colonoscopy in this sub
select group of patient. Furthermore there was no
correlation between the abdominal symptoms and
the cytokeratin markers with respect to the primary
found in the GI tract. However these findings can
happen because of the poor yield of finding the
primary in the GI tract.
We would like to highlight some of the limitations
of this study. This was a single center tertiary
care referral study. Our cohort consisted of small
number of patients. But since CUP is not a very
common disease it would be very difficult to recruit
a large number of patients in a limited period of
time. Endoscopies are operator dependent and
carry a finite chance of missing a lesion depending
upon bowl preparation and various other factors.
Very limited number of patients had their primary
found as a result of endoscopies. Hence getting a
useful correlation in between the variables under
consideration was difficult.
Further studies are required so as to potentiate
findings depicted in this study particularly those
with higher number of patients having their primary known. Specifically those in which not only
symptom, immune-histochemistry and radiological
findings are taken into consideration.
CONCLUSION
The yield of finding a primary lesion by
gastroscopy and colonoscopy is limited. Abdominal
symptoms and cytokeratin markers do not seem to
reliably predict the presence of colonic or gastric
malignancies. More studies with a larger sample
size are needed to further validate our findings.
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